PTC Therapeutics Sets 2026 Revenue Guidance at $1.29B-$1.32B
PTC Therapeutics presented total revenue guidance of $1.29 billion to $1.32 billion for 2026.
Related stories
AbbVie Sees FY Adjusted EPS of $13.95–$13.99
H impact | EARNINGS | Oct 30, 2026, 11:46 AM UTC
AbbVie reports third-quarter EPS of $2.37
H impact | EARNINGS | Oct 30, 2026, 11:46 AM UTC
WEC Energy Group Reports 2026 Revenue of $2.29B, EPS of $1.18
WEC Energy Group reported net income of $390.3 million, up 44.4% from the prior-year period. Diluted EPS rose 42.2% to $1.18.
M impact | EARNINGS | Oct 30, 2026, 11:41 AM UTC
US stock futures fell for a second consecutive session as another batch of disappointing technology earnings deepened the sector selloff. Investors are increasingly questioning whether massive artificial-intelligence investments will deliver sufficient returns, while signs of slowing momentum in the core businesses of major US technology companies add to concerns.
US stock futures fell for a second consecutive session as another batch of disappointing technology earnings deepened the sector selloff. Investors are increasingly questioning whe
H impact | EARNINGS | Oct 30, 2026, 11:39 AM UTC
Cboe Sees 2026 Organic Net Revenue Growth in High Teens
Cboe Global Markets sees 2026 organic total net revenue growth in the “high teens” range.
M impact | EARNINGS | Oct 30, 2026, 11:38 AM UTC
General Dynamics Aerospace Operating Earnings Rose 19% in Third Quarter
General Dynamics said Aerospace segment operating earnings increased 19% year over year as Gulfstream delivered 40 aircraft during the quarter. The body is truncated after noting l
H impact | EARNINGS | Oct 30, 2026, 11:34 AM UTC